Multimodality treatment for anaplastic thyroid carcinoma - Treatment outcome in 75 patients

Radiotherapy and Oncology

Volumn 92, Issue 1, 2009, Pages 100-104

  Swaak Kragten, Annemarie T ^a   de Wilt, Johannes H W ^a   Schmitz, Paul I M ^a   Bontenbal, Marijke ^a   Levendag, Peter C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Anaplastic thyroid carcinoma; Hyperfractionated radiotherapy; Local control; Multimodality therapy; Prophylactic lung irradiation; Survival

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; ESOPHAGUS DISEASE; FEMALE; HUMAN; IRRADIATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PHARYNX DISEASE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; SUBTOTAL THYROIDECTOMY; THERAPY EFFECT; THYROID CARCINOMA; TREATMENT RESPONSE;

AGED; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 66949172038     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.02.016     Document Type: Article

References (16)

1. Wiseman S.M., Loree T.R., Rigual N.R., et al. Anaplastic transformation of thyroid cancer: review of clinical, pathologic, and molecular evidence provides new insights into disease biology and future therapy. Head Neck 25 (2003) 662-670
2. McIver B., Hay I.D., Giuffrida D.F., et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130 (2001) 1028-1034
3. Sugitani I., Kasai N., Fujimoto Y., et al. Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid. World J Surg 25 (2001) 617-622
4. Junor E.J., Paul J., and Reed N.S. Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18 (1992) 83-88
5. Ain K.B. Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches. Thyroid 8 (1998) 715-726
6. Nilsson O., Lindeberg J., Zedenius J., et al. Anaplastic giant cell carcinoma of the thyroid gland: treatment and survival over a 25-year period. World J Surg 22 (1998) 725-730
7. Levendag P.C., De Porre P.M., and van Putten W.L. Anaplastic carcinoma of the thyroid gland treated by radiation therapy. Int J Radiat Oncol Biol Phys 26 (1993) 125-128
8. Kim J.H., and Leeper R.D. Treatment of locally advanced thyroid carcinoma with combination doxorubicin and radiation therapy. Cancer 60 (1987) 2372-2375
9. Tennvall J., Lundell G., Wahlberg P., et al. Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer 86 (2002) 1848-1853
10. De Crevoisier R., Baudin E., Bachelot A., et al. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys 60 (2004) 1137-1143
11. Haigh P.I., Ituarte P.H., Wu H.S., et al. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91 (2001) 2335-2342
12. Tennvall J., Lundell G., Hallquist A., et al. Combined doxorubicin, hyperfractionated radiotherapy, and surgery in anaplastic thyroid carcinoma report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 74 (1994) 1348-1354
13. Venkatesh Y.S., Ordonez N.G., Schultz P.N., et al. Anaplastic carcinoma of the thyroid. A clinicopathologic study of 121 cases. Cancer 66 (1990) 321-330
14. Besic N., Hocevar M., Zgajnar J., et al. Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients. Langenbecks Arch Surg 390 (2005) 203-208
15. Ain K.B., Egorin M.J., and DeSimone P.A. Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group. Thyroid 10 (2000) 587-594
16. Yau T., Lo Cy., Epstein R.J., et al. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol 15 9 (2008) 2500-2505